Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

News Features

Reimbursement Issues Seem to Be Holding Renal Denervation Back

Todd Neale

December 19, 2024

News Features

‘Hot’ Doc? Radiation Exposure Risks of Interventionalists Aired in TV Special

L.A. McKeown

September 25, 2024

News Features

Going Solo: Can TAVI Be Performed Without a Surgical Safety Net?

Michael O'Riordan

January 22, 2024

News Features

From Mountains to Meds: A Grassroots Effort Is Restocking Cath Labs in Ukraine

L.A. McKeown

October 18, 2022

News Features

Bloodlines: How Far Should Cardiologists Go in Treating Family?

Todd Neale

March 10, 2022

News Features

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

Michael O'Riordan

December 23, 2021

News Features

Expired Cardiac Devices May Do Global Good, but Safety Unknown

Yael L. Maxwell

August 26, 2021

News Features

Roughly 80% of ESC Guideline Writers Have Financial COIs

Michael O'Riordan

April 01, 2021

News Features

Funding the Future: How Industry Support for CV Trials Could Evolve

Michael O'Riordan

December 17, 2020

News Features

Too Easy to Misconstrue: Is It Time to Ditch Periprocedural MI?

Michael O'Riordan

December 02, 2020

News Features

Year in Review: Endovascular Saw Paclitaxel Storm Rage, CLI Care Advance in 2019

L.A. McKeown

December 12, 2019

News Features

ISCHEMIA Fracas: Amid Charges of Moving the Goalposts, Investigators Come Out Swinging

Michael O'Riordan

March 23, 2018

News Features

Cardiologists Treating Syrian Refugees Call Missions an ‘Addictive’ Passion That Saves Lives

Yael L. Maxwell

January 12, 2018

News Features

Absorb Vanishes, but Can Other Bioresorbable Scaffolds Make Magic Happen?

Michael O'Riordan

September 13, 2017

News Features

Stents as Essential Medicine: India’s Cap on Stent Prices Could Have Ripples Around the Globe

Shelley Wood

May 05, 2017

News Features

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

Shelley Wood

December 30, 2016

News Features

Repaso del Año: Los Médicos Eligen las Noticias Más Importantes de 2016 en Cardiología Intervencionista y Más

Shelley Wood

December 30, 2016

News Features

PCSK9 Inhibitors: Good Early Responses With Pricey Drugs, but Doctors Still Waiting on Real Data

Michael O'Riordan

January 25, 2016

Advertisement

Reimbursement Issues Seem to Be Holding Renal Denervation Back

‘Hot’ Doc? Radiation Exposure Risks of Interventionalists Aired in TV Special

Going Solo: Can TAVI Be Performed Without a Surgical Safety Net?

From Mountains to Meds: A Grassroots Effort Is Restocking Cath Labs in Ukraine

Bloodlines: How Far Should Cardiologists Go in Treating Family?

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

Expired Cardiac Devices May Do Global Good, but Safety Unknown

Roughly 80% of ESC Guideline Writers Have Financial COIs

Funding the Future: How Industry Support for CV Trials Could Evolve

Too Easy to Misconstrue: Is It Time to Ditch Periprocedural MI?

Year in Review: Endovascular Saw Paclitaxel Storm Rage, CLI Care Advance in 2019

ISCHEMIA Fracas: Amid Charges of Moving the Goalposts, Investigators Come Out Swinging

Cardiologists Treating Syrian Refugees Call Missions an ‘Addictive’ Passion That Saves Lives

Absorb Vanishes, but Can Other Bioresorbable Scaffolds Make Magic Happen?

Stents as Essential Medicine: India’s Cap on Stent Prices Could Have Ripples Around the Globe

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

Repaso del Año: Los Médicos Eligen las Noticias Más Importantes de 2016 en Cardiología Intervencionista y Más

PCSK9 Inhibitors: Good Early Responses With Pricey Drugs, but Doctors Still Waiting on Real Data

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content